SAN FRANCISCO – At Glaucoma 360, Richard L. Lindstrom, MD, gives highlights from a panel discussion focused on teaching the best methods as well as challenges for entrepreneurs in developing a new product.
Uncategorized
Dartmouth study shows brain area involved in eye movements, heading
An area of the brain involved in eye movements also plays an important role in establishing our direction and navigating our environment, a Dartmouth College study finds.
Harborview’s MCICU receives gold-level Beacon Award for Excellence from AACN
Harborview Medical Center’s Medical Coronary Intensive Care Unit has received a gold-level Beacon Award for Excellence from the American Association of Critical-Care Nurses.
New Wave of Drugs Poised to Shake up Glaucoma Treatment
For the first time in 20 years, patients suffering from the eye disease glaucoma may soon have new treatments as several young companies look to shake up the $5.6 billion global market Reuters Health Information
Uncategorized
STAAR works to correct observed deficits in good manufacturing practices
The FDA may withhold approval of new products such as the toric ICL or take additional regulatory or legal action against STAAR Surgical, unless and until STAAR corrects outstanding issues to the FDA’s satisfaction, according to a form the company issued to the Securities and Exchange Commission.
Uncategorized
Norman Jaffe, pioneer of IOL implantation, dies at 90
Norman Jaffe, MD, known for his contributions to IOL implantation techniques and education, has died. He was 90 years old. Jaffe was the founder of the Jaffe Eye Institute, a founder and president of the American Intraocular Implant Society, and a clinical professor at the University of Miami. He specialized in cataract surgery.Jaffe was one of a few surgeons to begin performing IOL implantation in cataract surgery, first performing the technique in 1967 and subsequently teaching the technique to thousands of ophthalmologists. In 1988, he and three of his sons (Read more...)